Lara Fallon

3.3k citations

62 papers · 2.4k indexed · 2 hit papers · h-index 21

Impact in

Rheumatology top 1%
- Spondyloarthritis Studies and Treatments
- Rheumatoid Arthritis Research and Therapies
Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments

Papers in ⓘ

Rheumatology 46
- Rheumatoid Arthritis Research and Therapies 33
- Spondyloarthritis Studies and Treatments 33
Hematology 25
- Autoimmune and Inflammatory Disorders Research 25

Co-authors: Peter T. Lansbury (1 shared paper)Zhihua Liu (1 shared paper)Hilal A. Lashuel (1 shared paper)Yichin Liu (1 shared paper)Edward A. Fon (4 shared papers)Michael C. Pirrung (4 shared papers)France Moreau (2 shared papers)Maria Kontogiannea (2 shared papers)
Journals: Annals of the Rheumatic Diseases (13 papers)Rheumatology and Therapy (8 papers)RMD Open (3 papers)ACR Open Rheumatology (2 papers)Arthritis Research & Therapy (2 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Lara Fallon

60 papers receiving 2.3k citations

Hit Papers

align trajectories log scale

Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study 2021 · 159 citations

Peers

Countries citing papers authored by Lara Fallon

Since Specialization

Citations

This map shows the geographic impact of Lara Fallon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Fallon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Fallon more than expected).

Fields of papers citing papers by Lara Fallon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara Fallon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Fallon. The network helps show where Lara Fallon may publish in the future.

Co-authors

The 25 scholars most cited alongside Lara Fallon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lara Fallon Line = papers co-authored together Lara Fallon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The UCH-L1 Gene Encodes Two Opposing Enzymatic Activities that Affect α-Synuclein Degradation and Parkinson's Disease Susceptibility Cell ·Yichin Liu, Lara Fallon, Hilal A. Lashuel, Zhihua Liu, Peter T. Lansbury Hit paper breakdown →	2002	652
2	A regulated interaction with the UIM protein Eps15 implicates parkin in EGF receptor trafficking and PI(3)K–Akt signalling Nature Cell Biology ·Lara Fallon, Catherine M.L. Bélanger, Amadou T. Corera, Maria Kontogiannea, Elsa Regan‐Klapisz, France Moreau, Jarno Voortman, Michael Haber, Geneviève Rouleau, Thorhildur Thorarinsdottir, Alexis Brice, Paul M.P. van Bergen en Henegouwen, Edward A. Fon	2006	295
3	Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study Annals of the Rheumatic Diseases ·Atul Deodhar, Paula Śliwińska-Stańczyk, Huji Xu, Xenofon Baraliakos, Lianne S. Gensler, Dona Fleishaker, Lisy Wang, Joseph Wu, Sujatha Menon, Cunshan Wang, Oluwaseyi Dina, Lara Fallon, Keith S. Kanik, Désirée van der Heijde Hit paper breakdown →	2021	159
4	Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data Annals of the Rheumatic Diseases ·Philip J. Mease, Christina Charles‐Schoeman, Stanley Cohen, Lara Fallon, John Woolcott, Huifeng Yun, Joel M. Kremer, Jeffrey D. Greenberg, Wendi Malley, Alina Onofrei, Keith S. Kanik, Daniela Graham, Cunshan Wang, Carol A. Connell, Hernán Valdez, Manfred Hauben, Eric Hung, Ann Madsen, Thomas V. Jones, Jeffrey R. Curtis	2020	153
5	Parkin and CASK/LIN-2 Associate via a PDZ-mediated Interaction and Are Co-localized in Lipid Rafts and Postsynaptic Densities in Brain Journal of Biological Chemistry ·Lara Fallon, France Moreau, Benjamin G. Croft, Noura Labib, Wen‐Jie Gu, Edward A. Fon	2002	152
6	The Machado–Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability Human Molecular Genetics ·Thomas M. Durcan, Maria Kontogiannea, Thorhildur Thorarinsdottir, Lara Fallon, Aislinn Williams, Ana Djarmati, Tadeu A. Fantaneanu, Henry L. Paulson, Edward A. Fon	2010	123
7	Management of ureteral stenosis after renal transplantation. PubMed ·B Lojanapiwat, Deepak Mital, Lara Fallon, Harvey A. Koolpe, R Raja, F Badosa, Christopher Po, Michael C. Morris	1994	73
8	Proofing of Photolithographic DNA Synthesis with 3‘,5‘-Dimethoxybenzoinyloxycarbonyl-Protected Deoxynucleoside Phosphoramidites The Journal of Organic Chemistry ·Michael C. Pirrung, Lara Fallon, Glenn H. McGall	1998	63
9	Ubiquilin recruits Eps15 into ubiquitin-rich cytoplasmic aggregates via a UIM-UBL interaction Journal of Cell Science ·Elsa Regan‐Klapisz, Irina Sorokina, Jarno Voortman, Peter L.J. de Keizer, Rob C. Roovers, Peter Verheesen, Sylvie Urbé, Lara Fallon, Edward A. Fon, Arie J. Verkleij, Alexandre Benmerah, Paul M.P. van Bergen en Henegouwen	2005	57
10	A convenient procedure for the deprotection of silylated nucleosides and nucleotides using triethylamine trihydrofluoride Bioorganic & Medicinal Chemistry Letters ·Michael C. Pirrung, Steven W. Shuey, Davic C. Lever, Lara Fallon	1994	49
11	Safety and Efficacy of Tofacitinib in Patients with Active Psoriatic Arthritis: Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study Rheumatology and Therapy ·Peter Nash, Laura C. Coates, Alan Kivitz, Philip J. Mease, Dafna D. Gladman, Jose A Covarrubias-Cobos, Oliver FitzGerald, Dona Fleishaker, Cunshan Wang, Joseph Wu, Ming‐Ann Hsu, Sujatha Menon, Lara Fallon, Ana Belén Romero, Keith S. Kanik	2020	48
12	FRI0335 THE EFFECT OF TOFACITINIB ON RESIDUAL PAIN IN PATIENTS WITH PSORIATIC ARTHRITIS Annals of the Rheumatic Diseases ·Maxime Dougados, Désirée van der Heijde, Clifton O. Bingham, Peter C. Taylor, Lara Fallon, John Woolcott, Y. Brault, L. Wang, M. Kessouri	2020	43
13	Effects of Molecular Area on the Polymerization and Thermochromism of Langmuir-Blodgett Films of Cd2+ Salts of 5,7-Diacetylenes Studied Using UV-Visible Spectroscopy Langmuir ·A. A. Deckert, Jennifer C. Horne, Barry Valentine, Lisa Kiernan, Lara Fallon	1995	41
14	Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire Health and Quality of Life Outcomes ·Laura C. Coates, Ana‐Maria Orbai, Valderílio Feijó Azevedo, Joseph C. Cappelleri, Kathy Steinberg, Roger Lippé, Irwin Lim, Lihi Eder, Pascal Richette, Meng‐Yu Weng, Rubén Queiró, Lara Fallon	2020	39
15	Radiographic Progression According to Baseline C-reactive Protein Levels and Other Risk Factors in Psoriatic Arthritis Treated with Tofacitinib or Adalimumab The Journal of Rheumatology ·Désirée van der Heijde, Dafna D. Gladman, Oliver FitzGerald, Arthur Kavanaugh, Daniela Graham, Cunshan Wang, Lara Fallon	2019	39
16	Kinetics of the Reversible Thermochromism in Langmuir-Blodgett Films of Cd2+ Salts of Polydiacetylenes Studied Using UN-Vis Spectroscopy Langmuir ·A. A. Deckert, Lara Fallon, Lisa Kiernan, Christopher Cashin, Anthony Perrone, Terry Encalarde	1994	37
17	Inverse Phosphotriester DNA Synthesis Using Photochemically-Removable Dimethoxybenzoin Phosphate Protecting Groups The Journal of Organic Chemistry ·Michael C. Pirrung, Lara Fallon, David C. Lever, Steven W. Shuey	1996	33
18	Photochemically Removable Silyl Protecting Groups Journal of the American Chemical Society ·Michael C. Pirrung, Lara Fallon, Jin Zhu, Yong Rok Lee	2001	32
19	Safety and efficacy of tofacitinib up to 48 months in patients with active psoriatic arthritis: final analysis of the OPAL Balance long-term extension study The Lancet Rheumatology ·Peter Nash, Laura C. Coates, Dona Fleishaker, Alan Kivitz, Philip J. Mease, Dafna D. Gladman, Oliver FitzGerald, Cunshan Wang, Joseph Wu, Ming‐Ann Hsu, Sujatha Menon, Lara Fallon, Keith S. Kanik	2021	27
20	Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trial RMD Open ·Victoria Navarro‐Compán, James Cheng‐Chung Wei, Filip Van den Bosch, Marina Magrey, Lisy Wang, Dona Fleishaker, Joseph C. Cappelleri, Cunshan Wang, Joseph Wu, Oluwaseyi Dina, Lara Fallon, Vibeke Strand	2022	27

About Lara Fallon

Lara Fallon is a scholar working on Rheumatology, Hematology, Immunology, Molecular Biology and Genetics, having authored 62 papers that have together received 2.4k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (33 papers), Spondyloarthritis Studies and Treatments (33 papers), Autoimmune and Inflammatory Disorders Research (25 papers), Psoriasis: Treatment and Pathogenesis (17 papers), Chronic Lymphocytic Leukemia Research (4 papers), Biosimilars and Bioanalytical Methods (4 papers), Ubiquitin and proteasome pathways (4 papers) and Advanced biosensing and bioanalysis techniques (3 papers). The work is most often cited by research in Rheumatology (625 citations), Neurology (504 citations), Hematology (317 citations), Cellular and Molecular Neuroscience (403 citations) and Immunology (391 citations). Lara Fallon has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Peter T. Lansbury, Zhihua Liu, Hilal A. Lashuel, Yichin Liu, Edward A. Fon, Michael C. Pirrung, France Moreau, Maria Kontogiannea, Cunshan Wang and Paul M.P. van Bergen en Henegouwen. Their work appears in journals such as Annals of the Rheumatic Diseases, Rheumatology and Therapy, RMD Open, ACR Open Rheumatology and Arthritis Research & Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact